Patisiran was approved by FDA recently for
It is a double stranded small interfering ribose neuclic acid ( si RNA) formulated in the form of a lipid complex. used in the treatment of polyneuropathy
Filariasis
Peripheral Neuropathy
Neuropathy of diabetes
Neuropathy of amyloidosis
All India exam